Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
On Apr. 30, 2020, Eiger BioPharmaceuticals announced that the first patients have been dosed in a Phase 2…
On Apr. 30, 2020, Eiger BioPharmaceuticals announced that the first patients have been dosed in a Phase 2…
On Apr. 30, 2020, an international team of more than 120 scientists has detailed the impact of 75…
On Apr. 30, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
On Apr. 30, 2020, Emory University researchers are taking part in a multi-site study across the U.S. to…
On Apr. 30, 2020, Tyson announced a partnership with Matrix Medical Network to help ensure the safety and…
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…
On Apr. 30, 2020, InBios announced that it had been awarded a contract from the Biomedical Advanced Research…
On Apr. 29, 2020, the NIH announced a new $1.5 billion federal stimulus funding initiative aimed to speed…
On Apr. 29, 2020, the National Institutes of Health (NIH) announced that hospitalized patients with advanced COVID-19 and…
On Apr. 29, 2020, the U.S. Dep. of Veterans Affairs (VA) announced a partnership with the XPRIZE Foundationメs…
On Apr. 29, 2020, the NIH announced a new initiative aimed at speeding innovation, development and commercialization of…
On Apr. 29, 2020, Gilead announced topline results from the open-label, Phase 3 SIMPLE trial evaluating 5-day and…
On Apr. 29, 2020, an anti-inflammatory drug developed at Scripps Research 25 years ago tested as a way…
On Apr. 29, 2020, Scripps researchers announced they had developed a method for examining the machinery of HIV…
On Apr. 29, 2020, Emory University played a leading role in the government-sponsored clinical trial of the COVID-19…
On Apr. 29, 2020, Hologic announced that it planned to launch a new Aptimaᆴ molecular assay to detect…
On Apr. 29, 2020, hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than…
On Apr. 29, 2020, Catalent announced a collaboration with the Janssen Pharmaceutical Companies of Johnson & Johnson, whereby…
On Apr. 29, 2020, Chimerix announced initiation of a Phase 2/3 study of dociparstat sodium (DSTAT) in COVID-19…
On Apr. 29, 2020, BioReference Laboratories, an OPKO Health company, announced that it will continue to prioritize COVID-19…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine and NYU Langone…
On Apr. 29, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine announced that they…
On Apr. 29, 2020, Windtree Therapeutics announced it has enrolled the first patient into its AEROSURF phase 2b…
On Apr. 29, 2020, a team of Texas A&M University researchers asked hundreds of frontline medical workers to…
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax. This partnership combined the Entos Fusogenix DNA…
On Apr. 28, 2020, the Dutch consortium of AFPRO Filters, Royal Auping, and Royal DSM began large-scale production…
On Apr. 28, 2020, Illumina announced that the African Union Commission, on behalf of the Africa Center for…
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
On Apr. 28, 2020, Sarepta Therapeutics announced the Company and the USAMRIID, the Department of Defense’s lead laboratory…
On Apr. 28, 2020, Quest Diagnostics announced that individuals can purchase COVID-19 antibody testing for themselves online, without…